Mochida Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3922800002
JPY
3,585.00
100 (2.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
32,502.00
28,354.00
26,631.00
24,428.00
29,635.00
25,689.00
25,407.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
32,502.00
28,354.00
26,631.00
24,428.00
29,635.00
25,689.00
25,407.00
Raw Material Cost
17,495.00
15,128.00
13,005.00
12,089.00
13,471.00
13,360.00
12,451.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
29.00
1.00
0.00
1.00
1.00
0.00
0.00
Selling and Distribution Expenses
8,766.00
8,317.00
8,265.00
8,529.00
8,740.00
8,279.00
8,437.00
Other Expenses
365.30
251.30
278.80
292.60
397.20
244.70
232.90
Total Expenditure (Excl Depreciation)
29,943.00
25,959.00
24,058.00
23,545.00
26,184.00
24,086.00
23,217.00
Operating Profit (PBDIT) excl Other Income
2559
2395
2573
883
3451
1603
2190
Other Income
642.00
3.00
211.00
-459.00
110.00
102.00
175.00
Operating Profit (PBDIT)
3,970.00
3,123.00
3,480.00
1,197.00
4,310.00
2,418.00
3,070.00
Interest
29.00
1.00
0.00
1.00
1.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
15,007.00
13,226.00
13,626.00
12,339.00
16,164.00
12,329.00
12,956.00
Depreciation
769.00
725.00
696.00
773.00
749.00
713.00
705.00
Profit Before Tax
3,167.00
2,398.00
2,782.00
423.00
3,561.00
1,704.00
2,364.00
Tax
681.00
435.00
888.00
344.00
781.00
433.00
809.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,486.00
1,962.00
1,894.00
80.00
2,780.00
1,271.00
1,554.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,486.00
1,962.00
1,894.00
80.00
2,780.00
1,271.00
1,554.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,486.00
1,962.00
1,894.00
80.00
2,780.00
1,271.00
1,554.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,37,431.00
1,35,206.00
1,31,152.00
1,30,694.00
1,30,316.00
1,29,106.00
1,27,396.00
Earnings per share (EPS)
70.13
55.35
53.43
2.26
78.42
35.85
43.83
Diluted Earnings per share
70.13
55.35
53.43
2.26
78.42
35.85
43.83
Operating Profit Margin (Excl OI)
7.87%
8.45%
9.66%
3.61%
11.65%
6.24%
8.62%
Gross Profit Margin
12.11%
11.01%
13.06%
4.9%
14.54%
9.41%
12.08%
PAT Margin
7.65%
6.92%
7.11%
0.33%
9.38%
4.95%
6.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 9.67% vs 3.11% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is -10.58% vs 73.10% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -20.76% vs 63.55% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 2,800.00% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Mochida Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
32,502.00
73,589.00
-41,087.00
-55.83%
Other Operating Income
0.00
0.00
0.00
Total Operating income
32,502.00
73,589.00
-41,087.00
-55.83%
Raw Material Cost
17,495.00
45,674.00
-28,179.00
-61.70%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
29.00
532.00
-503.00
-94.55%
Selling and Distribution Expenses
8,766.00
18,867.00
-10,101.00
-53.54%
Other Expenses
365.30
-53.20
418.50
786.65%
Total Expenditure (Excl Depreciation)
29,943.00
64,541.00
-34,598.00
-53.61%
Operating Profit (PBDIT) excl Other Income
2,559.00
9,048.00
-6,489.00
-71.72%
Other Income
642.00
455.00
187.00
41.10%
Operating Profit (PBDIT)
3,970.00
15,383.00
-11,413.00
-74.19%
Interest
29.00
532.00
-503.00
-94.55%
Exceptional Items
0.00
3,023.00
-3,023.00
-100.00%
Gross Profit (PBDT)
15,007.00
27,915.00
-12,908.00
-46.24%
Depreciation
769.00
5,880.00
-5,111.00
-86.92%
Profit Before Tax
3,167.00
11,995.00
-8,828.00
-73.60%
Tax
681.00
3,127.00
-2,446.00
-78.22%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,486.00
8,868.00
-6,382.00
-71.97%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,486.00
8,868.00
-6,382.00
-71.97%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,486.00
8,868.00
-6,382.00
-71.97%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,37,431.00
1,89,689.00
-52,258.00
-27.55%
Earnings per share (EPS)
70.13
180.14
-110.01
-61.07%
Diluted Earnings per share
70.13
180.14
-110.01
-61.07%
Operating Profit Margin (Excl OI)
7.87%
12.30%
0.00
-4.43%
Gross Profit Margin
12.11%
24.29%
0.00
-12.18%
PAT Margin
7.65%
12.05%
0.00
-4.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,250.20 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 14.63% vs 6.47% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 9.67% vs 3.11% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 248.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 26.71% vs 3.59% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -10.58% vs 73.10% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 332.80 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 6.67% vs -4.56% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -20.76% vs 63.55% in Dec 2024

Quarterly - Interest
Interest 2.90 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 2,800.00% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 2,800.00% vs 0.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.87%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024